IBRN vs IHI: Holdings Overlap & Returns

Over the year to Nov 13, 2026, IBRN returned +19.8% to IHI's −7.4%; 1% of their weight is in the same names.

Return gap
+27.2 pts1 year to Nov 13, 2026: IBRN ahead, total return
Fee gap
0.10 ptsA year: IBRN 0.47%, IHI 0.37%, per filings dated Nov 21, 2025 and Jul 27, 2026
Overlap
1%Share of the two books held in common, holdings dated Nov 12, 2026
Net flow
+$2m / +$76mIBRN / IHI, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
IBRN and IHI · 1 year

Growth of 100

IBRN +19.8%IHI −7.4%
Growth of 100 in IBRN and IHI over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. IBRN ends at 119.8 (+19.8%), IHI at 92.6 (−7.4%).

IBRN +19.8%, IHI −7.4%: IBRN +27.2 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

IBRN and IHI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in IBRN costs about $16.00 one way and $32.00 in and out, at a median spread of 0.32%. The 0.32% spread is IBRN’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in IBRN for 10 years at 0.47% a year costs about $778 in fees and lost growth; IHI at 0.37% would cost $615. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

IBRN · 1 year to Nov 13, 202695% of its weight is outside the S&P 500
95% of its weight is outside the S&P 5005% of IBRN's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 12, 2026.5%95%inof its weight outside the S&P 500active share 100% · top ten 45% of the fund · 67 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 0% in95% of its weight is outside the S&P 5005% of IBRN's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 12, 2026.5%95%5% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · Nasdaq-100: 0% in

5% of IBRN's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 12, 2026.

IHI · 1 year to Nov 13, 202612% of its weight is outside the S&P 500
12% of its weight is outside the S&P 50089% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.89%12%of its weight in S&P 500 companiesoutsideactive share 99% · top ten 76% of the fund · 51 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 28% in12% of its weight is outside the S&P 50089% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.89%12%of its weight in S&P 500 companies12% of its weight outside the S&P 500active share 99% · Nasdaq-100: 28% in

89% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.

Key numbers

IBRN in the S&P 500
5.3%
IHI in the S&P 500
88.5%
IBRN total return, 1 year
+19.8%
IHI total return, 1 year
−7.4%

IHI costs 0.10 points a year less; their one-year returns differ by 27.2 points; IHI is far larger, $4.0bn against $8.6m.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+19.8%−7.4%
Below its all-time high15.9%, high on Aug 19, 202611.5%, high on Sep 8, 2021
What it tracksTherapeutics and medical devicesTherapeutics and medical devices
Expense ratio0.47%0.37%
Net assets, as of Nov 12, 2026$8.6m$4.0bn
Holdings in common1%

The numbers behind it

Net assets: $8.6m on Nov 12, 2026 for iShares Neuroscience and Healthcare ETF, and $4.1bn on Nov 13, 2026 for iShares U.S. Medical Devices ETF.

Holdings in common uses holdings dated Nov 12, 2026.

What they share

By the books each fund has filed, IBRN and IHI hold 1% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026.

0half (50%)100%

half

1% in common

Held in common

Show all 3 holdings
AXOGEN4.28%0.41%
INTEGRA LIFESCIENCES HOLDINGS1.05%0.12%
CERIBELL1.00%0.08%

Only in IBRN

Show all 8 holdings
BIOGEN5.33%
NEUROCRINE BIOSCIENCES5.09%
EDGEWISE THERAPEUTICS4.96%
Alkermes Public Limited Company4.75%
ARGENX SE ADR4.43%
PRAXIS PRECISION MEDICINES4.30%
PTC THERAPEUTICS4.29%
DIANTHUS THERAPEUTICS3.98%

Only in IHI

Show all 8 holdings
ABBOTT LABORATORIES17.27%
INTUITIVE SURGICAL14.46%
MEDTRONIC PLC11.51%
IDEXX LABORATORIES5.48%
EDWARDS LIFESCIENCES4.96%
BECTON DICKINSON AND CO4.85%
GE HEALTHCARE TECHNOLOGIES4.63%
STRYKER4.59%

Side by side

Open the table
FundiShares Neuroscience and Healthcare ETF · Holds 67 stocks in therapeutics and medical devices, 5% of its weight in S&P 500 companiesiShares U.S. Medical Devices ETF · Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies
IssueriSharesiShares
ThemeTherapeutics and medical devicesTherapeutics and medical devices
In the S&P 5005.3%88.5%
Active share vs the S&P 500100.0%98.7%
In the Nasdaq-1000.0%28.4%
Holdings6751
Top ten, share of the fund45.2%76.0%
Expense ratio0.47%0.37%
Fee for the differing part0.47%0.37%
Total return, 1 year+19.8%−7.4%
vs its benchmarknot measurednot measured
Below its high−15.9%−11.5%
Net assets, IBRN as of Nov 12, 2026 and IHI as of Nov 13, 2026$8.6m$4.1bn

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months−12.6%+4.2%
6 months−1.7%+20.1%
1 year+19.8%−7.4%
3 years+67.5%+23.4%
Since launch (Not the same days: IBRN Aug 2022 · IHI May 2006)+41.2%+658.0%

About IBRN

By weight, 5% of IBRN's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 45% of the fund across 67 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +19.8% with distributions reinvested. It sits 15.9% below its all-time high of Aug 19, 2026.

About IHI

By weight, 88% of IHI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 76% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned −7.4% with distributions reinvested. It sits 11.5% below its all-time high of Sep 8, 2021.

1% of the two portfolios are the same securities at the same weight.

Questions people ask

Do IBRN and IHI hold the same stocks?

By their latest filings, 1% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, IBRN or IHI?

IBRN has 5% of its weight in S&P 500 names and IHI has 88%, so IBRN differs more from the index.

Which is cheaper, IBRN or IHI?

IBRN charges 0.47% a year and IHI charges 0.37%, so IHI is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, IBRN against IHI, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ibrn-vs-ihi

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.